NCT07412041
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Stage II Lung Cancer. Study availability and eligibility vary by location and protocol.
NCT07412041
NCT05281237
NCT06383988
NCT06593106
NCT03493789
NCT05025748